isoniazid has been researched along with aconiazide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Held, HR; Landi, S | 1 |
Kodell, RL; West, RW | 2 |
Dooley, KL; Hansen, EB; Thompson, HC | 1 |
Bosch, RJ; Ryan, LM; Wypij, D | 1 |
Hauschke, D; Hothorn, LA | 1 |
6 other study(ies) available for isoniazid and aconiazide
Article | Year |
---|---|
Binding of toxic metabolites of isoniazid by aconiazide.
Topics: Antitubercular Agents; Carcinogens; Glycolates; Hydrazines; Isoniazid; Phenoxyacetates | 1980 |
Upper confidence limits on excess risk for quantitative responses.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hazardous Substances; Humans; Isoniazid; Models, Statistical; Monte Carlo Method; Probability; Rats; Rats, Inbred F344; Risk Factors; Weight Loss | 1993 |
High-performance liquid chromatographic analysis of the antituberculosis drugs aconiazide and isoniazid.
Topics: Animals; Antitubercular Agents; Chromatography, High Pressure Liquid; Electrochemistry; Female; Hydrolysis; Isoniazid; Male; Oxidation-Reduction; Rats; Rats, Inbred F344; Solutions | 1995 |
A semiparametric approach to risk assessment for quantitative outcomes.
Topics: Animals; Environmental Exposure; Environmental Pollutants; Female; Humans; Isoniazid; Models, Statistical; Monte Carlo Method; No-Observed-Adverse-Effect Level; Rats; Rats, Inbred F344; Regression Analysis; Risk Assessment; Weight Gain | 1996 |
Identifying the maximum safe dose: a multiple testing approach.
Topics: Animals; Antitubercular Agents; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Isoniazid; No-Observed-Adverse-Effect Level; Normal Distribution; Paget Disease, Extramammary; Randomized Controlled Trials as Topic; Rats; Statistics as Topic; Statistics, Nonparametric; Toxicology | 2000 |
A comparison of methods of benchmark-dose estimation for continuous response data.
Topics: Animals; Antitubercular Agents; Benchmarking; Bias; Computer Simulation; Confidence Intervals; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Isoniazid; Likelihood Functions; Linear Models; Models, Statistical; Monte Carlo Method; Normal Distribution; Pharmaceutical Preparations; Probability; Rats; Rats, Inbred F344; Reproducibility of Results; Risk Assessment; Weight Gain | 1999 |